SINOPHARM - stock earnings
1099.HK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 2.5 billion CNY | 155.4 billion CNY |
| 2023Q1 | 1.6 billion CNY | 145.5 billion CNY |
| 2022Q4 | 2.7 billion CNY | 145.8 billion CNY |
| 2022Q3 | 2.2 billion HKD | 144.9 billion HKD |
| 2022Q2 | 2.3 billion HKD | 133.9 billion HKD |
| 2021Q4 | 2.1 billion HKD | 139.8 billion HKD |
| 2021Q3 | 2.1 billion CNY | 132.2 billion CNY |
| 2021Q1 | 1.2 billion CNY | 120.3 billion CNY |
1099.HK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 8.5 billion CNY | 552.1 billion CNY |
| 2021 | 7.8 billion HKD | 521.1 billion HKD |
| 2020 | 7.2 billion HKD | 456.4 billion HKD |
| 2019 | 6.3 billion HKD | 425.3 billion HKD |
| 2018 | 5.8 billion HKD | 344.5 billion HKD |
1099.HK
Price: HK$19.62
Dividend Yield: 0.04%
Forward Dividend Yield: 4.64%
Payout Ratio: 28.70%
Dividend Per Share: 0.90 HKD
Earnings Per Share: 3.14 HKD
P/E Ratio: 6.70
Exchange: HKG
Sector: Healthcare
Industry: Medical Distribution
Volume: 1.3 million
Market Capitalization: 60.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 14
DGR3: 9.76%
DGR5: 10.77%